Quantcast

Latest tumour Stories

2009-01-13 11:54:30

Researcher Kristina Djanashvili has developed a substance that enables doctors to get better MRI scans of tumours. On Tuesday 13 January, Djanashvili will be awarded a doctorate by TU Delft for her work in this field.The medical profession's ability to trace and visualise tumours is increasing all the time. Detection and imaging techniques have improved enormously in recent years. One of the techniques that have come on by leaps and bounds is MRI. Patients who are going to have MRI scans are...

2008-10-23 06:00:12

NERVIANO, Italy, October 23 /PRNewswire/ -- - First Responses in Solid Tumours Reported. Aurora inhibitors play a key role in cell duplication and are implicated in both the onset and progression of numerous types of tumour. A lecture focusing on Aurora kinase inhibitors will be presented today by Dr. Bernard Laffranchi during the 20th EORTC-NCI-AACR Symposium "Molecular Targets and Cancer Therapeutics" organised from 21st to 24th October 2008 in Geneva. Dr Laffranchi, Director Clinical...

2008-09-06 21:00:04

Many breast cancers are made worse by the hormone oestrogen and women take drugs known as aromatase inhibitors to reduce the oestrogen in their body and restrict the cancer's progress. But eventually the tumour becomes resistant to this treatment and starts to grow.Now American researchers said a drug called sorafenib may be able to reverse this process."At first, the tumour's growth is halted because the aromatase inhibitor is depriving the cancer of the oestrogen it needs to grow," says...

2008-09-01 03:00:15

GENEVA, Sept. 1 /PRNewswire/ -- Chrigu from Switzerland has been awarded the Grand Prize in the first ever Reel Lives: Cancer Chronicles Film Festival at a ceremony in Geneva, Switzerland. Runners up prizes were also awarded to The Truth About Cancer (USA) for Best Reportage, The Art of Living (India) for Best Personal Story, The Children of Avenir (Morocco) for Best Organizational Film and Hookah (Israel) for the best Public Service Announcement. Award winners were chosen from an...

2008-08-29 03:00:19

By Chotel, F Unnithan, A; Chandrasekar, C R; Parot, R; Jeys, L; Grimer, R J We have analysed the pattern of symptoms in patients presenting with synovial sarcoma to identify factors which led to long delays in diagnosis. In 35 children, the early symptoms and the results of clinical and radiological investigation were reviewed, along with the presumed diagnoses. The duration of symptoms was separated into patient delay and doctor delay. Only half of the patients had one or more of the four...

2008-08-28 15:00:24

By PALMER, Rebecca ITS name is an unfamiliar mouthful and it is not one of "big cancers". But glioblastoma multiforme is the most common and aggressive primary brain tumour -- and there's no cure. "Despite intense efforts, there's really been little progress made over the last few decades in terms of outcome," says Wellington Hospital neurosurgeon Martin Hunn. "Even with the best treatment we have, which is a combination of surgery, radiotherapy and chemotherapy, the median survival is...

2008-08-15 03:00:10

London, UK, and Cambridge, MA, 15 August 2008 - Antisoma plc (LSE: ASM; USOTC: ATSMY) today announced survival data from its phase II study of ASA404 in hormone-refractory prostate cancer, in which patients were randomised to receive either 1200 mg/m2 ASA404 plus the chemotherapy drug docetaxel or a control treatment of docetaxel alone. The hazard ratio expressing the relative risk of death in the ASA404 and control groups favoured the ASA404 group (hazard ratio 0.8; 95% confidence...

2008-08-13 18:00:12

By JOHN VON RADOWITZ A TREATMENT for brittle bones has a dramatic effect on breast cancer when combined with chemotherapy, research has shown. Scientists found that the two drugs acted together to slow down the growth of tumours. In mice given the therapy, growing breast tumours were almost stopped in their tracks. A clinical trial is now under way in the UK which could lead to the treatment becoming widely available to patients. Since both drugs are already well established this may...

2008-07-20 03:00:15

By El-Abd, E El-Tahan, R; Fahmy, L; Zaki, S; Faid, W; Sobhi, A; Kandil, K; El-Kwisky, F ABSTRACT This study investigates the possible prognostic role of serum metastasin messenger RNA (mRNA) in breast carcinoma as a non- invasive screening tool, and determines metastasin mRNA in the serum of breast cancer patients with high sensitivity (85%) and specificity (100%). A significant difference (P=0.05) was observed between serum metastasin mRNA and the number of involved lymph nodes. Patients...

2008-06-19 09:00:00

By Jeremy Laurance Health Editor A 52-year-old man with advanced melanoma, the lethal form of skin cancer, has been successfully treated using just his own blood. The development has been hailed by British experts as an "exciting advance" in the use of cancer immunotherapy, which harnesses the body's immune system to fight the disease. Researchers in the US who were treating the patient extracted white blood cells, the key component of the immune system, and grew one type - the...


Word of the Day
sough
  • A murmuring sound; a rushing or whistling sound, like that of the wind; a deep sigh.
  • A gentle breeze; a waft; a breath.
  • Any rumor that engages general attention.
  • A cant or whining mode of speaking, especially in preaching or praying; the chant or recitative characteristic of the old Presbyterians in Scotland.
  • To make a rushing, whistling, or sighing sound; emit a hollow murmur; murmur or sigh like the wind.
  • To breathe in or as in sleep.
  • To utter in a whining or monotonous tone.
According to the OED, from the 16th century, this word is 'almost exclusively Scots and northern dialect until adopted in general literary use in the 19th.'
Related